Knight Therapeutics, a pan-American (ex-US) specialty pharmaceutical company, closed the syndication of its US$100 million secured revolving credit facility.On June 17, 2025, Knight had announced that it had closed a US$50 Million revolving credit...
Read Story
November 03, 2025, 07:52 AM
|
Knight Therapeutics, a pan-American (ex-US) specialty pharmaceutical company, has entered into a revolving credit facility, with National Bank of Canada (NBC).Knight has withdrawn C$60 million from the Credit Facility to fund a portion of the Paladin...
Read Story
June 18, 2025, 07:47 AM
|